Prostaglandins and the Kidney

Background: Synthesis and Nature

• Phospholipase A2 (in the inner cell membrane) cleaves membrane phospholipids to release arachidonic acid - the prime precursor
• Cyclooxygenase-1 (COX-1) and COX-2 act on arachidonic acid to produce prostaglandins
• Phospholipase A2 is activated by ischemia, hypotension, norepinephrine, angiotensin II, and arginine vasopressin (AVP) - essentially the same stress signals that cause renal vasoconstriction

1. Renal Hemodynamics (Blood Flow and GFR)

• The major renal vasodilatory prostaglandin is PGE2, synthesized predominantly in the medulla
• They dilate juxtamedullary blood vessels and maintain inner cortical blood flow - this is their most physiologically important renal role
• Vasodilation occurs through activation of cAMP, which opposes the actions of catecholamines, angiotensin II, and AVP
• They are particularly important in antagonizing angiotensin II's vasoconstriction on the afferent arteriole and mesangial cells
• Under normal resting conditions, prostaglandins have little influence on renal blood flow (RBF) - but they become critical under conditions of stress, hypotension, or volume depletion, when vasoconstrictors are activated

• Thromboxane A2 (TXA2) is the major vasoconstrictor prostaglandin, produced primarily in the renal cortex
• Prostaglandin F2 (PGF2) causes mesangial cell contraction, reducing the glomerular filtration surface area and lowering GFR
• In pathophysiologic states like acute kidney injury (AKI), TXA2 and various prostaglandins play a role in inflammation and abnormal vascular tone

• Mesangial cells contract (reducing GFR) in response to: angiotensin II, vasopressin, norepinephrine, histamine, endothelins, TXA2, leukotrienes C4/D4, PGF2, and platelet-activating factor
• Mesangial cells relax (increasing GFR) in response to: ANP, PGE2, and dopaminergic agonists

2. Tubular Effects: Sodium and Water Handling

• PGE2 inhibits sodium reabsorption in the distal nephron and collecting duct - this promotes natriuresis (sodium excretion)
• Prostaglandins act as anti-ADH/anti-aldosterone agents at the distal tubule: they increase sodium and water excretion, opposing the water-retaining effects of ADH
• From Campbell-Walsh Urology: "PGE2 inhibits Na reabsorption, and thus agents that decrease PGE2 production, including NSAIDs, can cause clinical signs of sodium retention"
• PGE2 also has a receptor-mediated effect on sodium and water transport in the proximal tubule

3. Renin Release

• PGE2 stimulates renin release from juxtaglomerular (JG) cells of the afferent arteriole
• PGE2 and nitric oxide at the macula densa are potential candidates for signal transmission to stimulate renin release
• This links prostaglandins to the renin-angiotensin-aldosterone system (RAAS) - paradoxically, prostaglandins stimulate renin (which causes vasoconstriction via Ang II) while also opposing Ang II's vasoconstrictive action on the renal vasculature

4. Medullary Protection

• Intrarenal prostaglandins serve as an endogenous renal protective system
• Stress states, renal ischemia, and hypotension simultaneously activate prostaglandin synthesis - so the factors that cause renal stress also activate the system that protects against it
• They are critical for maintaining medullary blood flow (via dilating vasa recta) in states of high sympathetic/RAAS activation
• In chronic kidney disease (CKD), renal PGE2 production is increased as a compensatory response to nephron loss

5. Ureteral Obstruction

• After acute ureteral obstruction, there is an initial prostaglandin-mediated vasodilation of the renal vasculature
• This is shortly followed by decreased renal blood flow and increased renal vascular resistance
• PGE2 plays a role in the initial pressure increase seen in the obstructed kidney

6. Clinical Relevance: NSAIDs and Renal Injury

• In healthy, well-hydrated patients: renal prostaglandins have little basal activity, so NSAIDs cause minimal renal effects
• In volume-depleted, hypotensive, or high-renin states: renal prostaglandins are actively vasodilating the afferent arteriole to preserve RBF and GFR - NSAIDs remove this protection and can cause:
  • Decreased GFR and acute kidney injury (AKI)
  • Sodium and water retention (edema, hypertension)
  • Hyperkalemia (via suppressed renin/aldosterone)
  • Reduced natriuretic response to diuretics
• From ROSEN's Emergency Medicine: "Prostaglandin produced by COX-1 causes renal vasodilation that maintains renal blood flow and the GFR. Inhibition of COX-1, especially in volume-depleted patients, can result in a decreased GFR and acute kidney injury"
• Patients on diuretics are particularly at risk because diuretics depend in part on prostaglandin-mediated vasodilation for their natriuretic response

Summary Table

• Miller's Anesthesia, 10e, "Prostaglandins and Kinins" section
• Tietz Textbook of Laboratory Medicine, 7e, "Prostaglandins and Thromboxanes" section
• Barash's Clinical Anesthesia, 9e, "Kidney Vasodilator Mechanisms"
• Morgan & Mikhail's Clinical Anesthesiology, 7e, "The Renal Corpuscle"
• Campbell-Walsh-Wein Urology, sodium/water handling section
• ROSEN's Emergency Medicine, "Nonsteroidal Antiinflammatory Drugs"
• Brenner and Rector's The Kidney, 2-Volume Set